Clinical Trial Update: Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated preoperative therapy with oxaliplatin, docetaxel, capecitabine, and radiation in resectable esophageal cancer; results were posted a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Esophagus Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-05-13